Neighborhood and HIV infection among IDU: Place of residence independently predicts HIV infection among a cohort of injection drug users

Health and Place

Volumn 13, Issue 2, 2007, Pages 432-439

  Maas, Benjamin ^a   Fairbairn, Nadia ^a   Kerr, Thomas ^a,b   Li, Kathy ^a   Montaner, Julio S G ^a,b   Wood, Evan ^a,b  

^a BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

HIV; IDU; Neighborhood; Risk environment; Vancouver

Indexed keywords

COHORT ANALYSIS; DRUG USER; HEALTH RISK; HUMAN IMMUNODEFICIENCY VIRUS; NEIGHBORHOOD; RISK FACTOR;

ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; DRUG USE; ENVIRONMENTAL FACTOR; FEMALE; HEALTH CARE POLICY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SEROCONVERSION; SOCIOECONOMICS; URBAN AREA;

BRITISH COLUMBIA; CANADA; NORTH AMERICA; VANCOUVER;

EID: 33846364256     PISSN: 13538292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healthplace.2006.05.005     Document Type: Article

References (45)

1. Buchanan D., Shaw S., Teng W., Hiser P., and Singer M. Neighborhood differences in patterns of syringe access, use, and discard among injection drug users: implications for HIV outreach and prevention education. Journal of Urban Health 80 3 (2003) 438-454
2. Carlson R.G. Shooting galleries, dope houses and injection doctors: examining the social ecology of HIV risk behaviors among drug injectors in Dayton, Ohio. Human Organization 59 (2000) 325-333
3. City of Vancouver. Downtown Eastside Community Monitoring Report. fifth ed (2000), Vancouver Planning Department, Vancouver
4. City of Vancouver. Downtown Eastside Community Monitoring Report. sixth ed (2001), Vancouver Planning Department, Vancouver
5. Des Jarlais D.C. Structural interventions to reduce HIV transmission among injecting drug users. AIDS 14 Suppl 1 (2000) S41-S46
6. Des Jarlais D.C., and Friedman S.R. Shooting galleries and AIDS: infection probabilities and 'tough' policies. American Journal of Public Health 80 2 (1990) 142-144
7. Des Jarlais D.C., Hagan H., Friedman S.R., Friedman P., Goldberg D., Frischer M., Green S., Tunving K., Ljungberg B., and Wodak A. Maintaining low HIV seroprevalence in populations of injecting drug users. Journal of American Medical Association 274 15 (1995) 1226-1231
8. Des Jarlais D.C., Paone D., Milliken J., Turner C.F., Miller H., Gribble J., Shi Q., Hagan H., and Friedman S.R. Audio-computer interviewing to measure risk behavior for HIV among injecting drug users: a quasi-randomized trial. Lancet 353 (1999) 1657-1661
9. Friedman S.R., Neaigus A., Jose B., Curtis R., Goldstein M., Ildefonso G., Rothenberg R.B., and Des Jarlais D.C. Sociometric risk networks and risk for HIV infection. American Journal of Public Health 87 8 (1997) 1289-1296
10. Friedman S.R., Kottiri B.J., Neaigus A., Curtis R., Vermund S.H., and Des Jarlais D.C. Network-related mechanisms may help explain long-term HIV-1 seroprevalence levels that remain high but do not approach population-group saturation. American Journal of Epidemiology 152 10 (2000) 913-922
11. Fuller C.M., Morrell L., Latkin C., Galea S., Ompad D., Strathdee S., and Vlahov D. Effects of race, neighborhood, and social network on age at initiation of injection drug use. American Journal of Public Health 95 4 (2005) 689-695
12. Galea S., Ahern J., and Vlahov D. Contextual determinants of drug use risk behavior: a theoretic framework. Journal of Urban Health 80 4 Suppl 3 (2003) iii50-iii58
13. Hamers F.F., and Downs A.M. HIV in central and eastern Europe. Lancet 361 9362 (2003) 1035-1044
14. Kerr T., Tyndall M., Li K., Montaner J., and Wood E. Safer injection facility use and syringe sharing in injection drug users. Lancet 366 9482 (2005) 316-318
15. Kitayaporn D., Uneklabh C., Weniger B.G., Lohsomboon P., Kaewkungwal J., Morgan W.M., and Uneklabh T. HIV-1 incidence determined retrospectively among drug users in Bangkok, Thailand. AIDS 8 10 (1994) 1443-1450
16. Kuyper L.M., Hogg R.S., Montaner J.S., Schechter M.I., and Wood E. The cost of inaction on HIV transmission among injection drug users and the potential for effective interventions. Journal of Urban Health 81 4 (2004) 655-660
17. Latkin C.A., and Curry A. Stressful neighborhoods and depression: a prospective study of the impact of neighborhood disorder. Journal of Health Social Behavior 44 1 (2003) 34-44
18. Latkin .A., Williams C.T., Wang J., and Curry A.D. Neighborhood social disorder as a determinant of drug injection behaviors: a structural equation modeling approach. Health Psychology 24 1 (2005) 96-100
19. Macalino G.E., Celentano D.D., Latkin C., Strathdee S.A., and Vlahov D. Risk behaviors by audio computer-assisted self-interviews among HIV seropositive and HIV-seronegative injection drug users. AIDS Education and Prevention 14 (2002) 367-378
20. McCord C., and Freeman H.P. Excess mortality in Harlem. New England Journal of Medicine 322 3 (1990) 173-177
21. Neaigus A., Friedman S.R.., Curtis R., Des Jarlais D.C., Furst R.T., Jose B., Mota P., Stepherson B., Sufian M., Ward T., et al. The relevance of drug injectors' social and risk networks for understanding and preventing HIV infection. Social Science Medicine 38 1 (1994) 67-78
22. Patrick D.M., Strathdee S.A., Archibald C.P., Ofner M., Craib K.J., Cornelisse P.G., Schechter M.T., Rekart M.L., and O'Shaughnessy M.V. Determinants of HIV seroconversion in injection drug users during a period of rising prevalence in Vancouver. International Journal of STD & AIDS 8 7 (1997) 437-445
23. Poundstone K.E., Strathdee S.A., and Celentano D.D. The social epidemiology of human immunodeficiency virus/acquired immunodeficiency syndrome. Epidemiologic Reviews 26 (2004) 22-35
24. Rhodes T. The 'risk environment': a framework for understanding and reducing drug-related harm. International Journal of Drug Policy 13 2 (2002) 85-94
25. Rhodes T., Mikhailova L., Sarang A., Lowndes C.M., Rylkov A., Khutorskoy M., and Renton A. Situational factors influencing drug injecting, risk reduction and syringe exchange in Togliatti City, Russian Federation: a qualitative study of micro risk environment. Social Science & Medicine 57 1 (2003) 39-54
26. Rhodes T., Singer M., Bourgois P., Friedman S.R., and Strathdee S.A. The social structural production of HIV risk among injecting drug users. Social Science & Medicine 61 5 (2005) 1026-1044
27. Rothenberg R.B., Long D., Sterk C.E., Pach A., Potterat J.J., Muth S., Baldwin J.A., and Trotter R.T. The Atlanta Urban Networks Study: a blueprint for endemic transmission. AIDS 14 14 (2000) 2191-2200
28. Shannon K., Ishida T., Lai C., and Tyndall M. The impact of unregulated single room occupancy hotels on the health status of illicit drug users in Vancouver. International Journal of Drug Policy 17 (2006) 107-114
29. Singer M. AIDS and the health crisis of the US urban poor: the perspective of critical medical anthropology. Social Science & Medicine 39 (1994) 931-948
30. Sinha R. How does stress increase risk of drug abuse and relapse?. Psychopharmacology (Berl) 158 4 (2001) 343-359
31. Statistics Canada. 1996. Population Census of Canada, Government of Canada.
32. Statistics Canada. Health Indicators (2001), Canadian Institute for Health Information, Ottawa
33. Strathdee S.A., Patrick D.M., Currie S.L., Cornelisse P.G., Rekart M.L., Montaner J.S., Schechter M.T., and O'Shaughnessy M.V. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS 11 8 (1997) F59-F65
34. Suh T., Mandell W., Latkin C., and Kim J. Social network characteristics and injecting HIV-risk behaviors among street injection drug users. Drug and Alcohol Dependence 47 2 (1997) 137-143
35. Tyndall M.W., Craig K.J., Currie S., Li K., O'Shaughnessy M.V., and Schechter M.T. Impact of HIV infection on mortality in a cohort of injection drug users. Journal of Acquired Immune Deficiency Syndromes 28 4 (2001) 351-357
36. Tyndall M.W., Currie S., Spittal P., Li K., Wood E., O'Shaughnessy M.V., and Schechter M.T. Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS 17 6 (2003) 887-893
37. Vancouver Coastal Health News Release, September 15, 2003. Injection Drug Use in the DTES.
38. Vlahov D., and Junge B. The role of needle exchange programs in HIV prevention. Public Health Report 113 Suppl 1 (1998) 75-80
39. Wallace R. Urban desertification, public health and public order: 'planned shrinkage', violent death, substance abuse and AIDS in the Bronx. Social Science & Medicine 31 7 (1990) 801-813
40. Wood E., Schechter M.T., Tyndall M.W., Montaner J.S., O'Shaughnessy M.V., and Hogg R.S. Antiretroviral medication use among injection drug users: two potential futures. AIDS 14 9 (2000) 1229-1235
41. Wood E., Tyndall M.W., Spittal P.M., Li K., Kerr T., Hogg R.S., Montaner J.S., O'Shaughnessy M.V., and Schechter M.T. Unsafe injection practices in a cohort of injection drug users in Vancouver: could safer injecting rooms help?. CMAJ 165 (2001) 405-410
42. Wood E., Kerr T., Small W., Li K., Marsh D.C., Montaner J.S., and Tyndall M.W. Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users. CMAJ 171 7 (2004) 731-734
43. Wood E., Patricia M., Spittal M., Small W., Kerr T., Li K., Hogg R.S., Tyndall M.W., Montaner J.S., and Schechter M.T. Displacement of Canada's largest public illicit drug market in response to a police crackdown. CMAJ 170 10 (2004) 1551-1556
44. Wood E., Kerr T., Lloyd-Smith E., Buchner C., Marsh D.C., Montaner J.S., and Tyndall M.W. Methodology for evaluating Insite: Canada's first medically supervised safer injection facility for injection drug users. Harm Reduction Journal 1 1 (2004) 9
45. Wood E., Li K., Miller C.L., Hogg R.S., Montaner J.S., Schechter M.T., and Kerr T. Baseline self-perceived risk of HIV infection independently predicts the rate of HIV seroconversion in a prospective cohort of injection drug users. International Journal of Epidemiology 34 1 (2005) 152-158